• Home
  • Media
  • Press Releases

Press Releases

Julphar Withdraws Cefuzime

2019-02-25
Julphar has taken the decision to withdraw certain batches of Cefuzime 250mg and 500mg tablets due to an issue over the product's stability. We take this issue very seriously and are working closely…

Julphar Announces 2018 Preliminary Results

2019-02-15
- Drop in revenue due to slowdown in certain markets - Company putting strategy in place to help strengthen financial health   Julphar, one of the largest pharmaceutical manufacturers in the Middle…

Julphar Launches Nationwide Healthy Living Initiative

2019-02-04
- Campaign aims to promote healthy eating and exercise in UAE - ‘Support and information key to cutting rates of obesity and diabetes,’ says General Manager   February 3, 2019, Ras Al…

Julphar Withdraws Zordyl

2019-01-29
We can confirm that we have withdrawn Zordyl mouthwash from all markets on the recommendations of the Saud Food and Drug Authority (SFDA). Zordyl is an antiseptic agent that maintains oral hygiene and…
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.